How This Evidence Evolved
Digital Pathology and AI
From glass slides to whole slide imaging and computational pathology
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
Pathologist sensitivity and specificity for prostate cancer: unassisted vs Paige Prostate-assisted reads of 610 biopsy WSIs (effect sizes not stated in abstract)
Diagnostic concordance between WSI and microscope
Major discordance with reference diagnosis: WSI 4.9% vs microscopy 4.6% (difference 0.4%, 95% CI -0.30% to 1.01%)
Follow-up studies, subgroup analyses, and real-world validation
Performance on a suite of 14 diverse benchmarks
Prediction of MSI directly from H&E histology in gastrointestinal cancer (performance figures not stated in abstract)
Performance on 34 computational pathology tasks
Specimen-level pan-cancer detection AUC 0.95 across nine common and seven rare cancers
BRAF prediction with internal cross-validation: mean AUC 0.9876 (95% CI 0.9744-1.0000); hypothesis-generating pending external validation
HRD prediction in held-out TCGA breast cancer H&E slides: AUC 0.81 (95% CI 0.77 to 0.85)
Current standard of care and ongoing research directions
Landmark Trials in This Story
Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care
Deep learning for histomorphology and personalized cancer care
Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer
AUC for metastasis detection vs pathologists
Clinical Validation of Artificial Intelligence-Augmented Pathology Diagnosis Demonstrates Significant Gains in Diagnostic Accuracy in Prostate Cancer Detection.
Pathologist sensitivity and specificity for prostate cancer: unassisted vs Paige Prostate-assisted reads of 610 biopsy WSIs (effect sizes not stated in abstract)
Validation of Digital Pathology for Primary Histopathological Diagnosis of Routine, Inflammatory Dermatopathology Cases
Diagnostic concordance between WSI and microscope
Whole Slide Imaging Versus Microscopy for Primary Diagnosis in Surgical Pathology: A Multicenter Blinded Randomized Noninferiority Study of 1992 Cases (Pivotal Study).
Major discordance with reference diagnosis: WSI 4.9% vs microscopy 4.6% (difference 0.4%, 95% CI -0.30% to 1.01%)
A visual-language foundation model for computational pathology
Performance on a suite of 14 diverse benchmarks
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer.
Prediction of MSI directly from H&E histology in gastrointestinal cancer (performance figures not stated in abstract)
Towards a general-purpose foundation model for computational pathology.
Performance on 34 computational pathology tasks
A foundation model for clinical-grade computational pathology and rare cancers detection.
Specimen-level pan-cancer detection AUC 0.95 across nine common and seven rare cancers
Single‑center weakly supervised deep learning prediction of KRAS, NRAS, BRAF, and HER2 status in colorectal cancer from histopathology images using internal cross‑validation.
BRAF prediction with internal cross-validation: mean AUC 0.9876 (95% CI 0.9744-1.0000); hypothesis-generating pending external validation
Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic Slides.
HRD prediction in held-out TCGA breast cancer H&E slides: AUC 0.81 (95% CI 0.77 to 0.85)
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.